Global Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks), Industry Trends and Forecast to 2029
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights
Infertility has become a major issue in both developed and developing economies in recent years. Infertility can be caused by a malfunction in either the male or female reproductive systems. Infertility is defined as the inability to become pregnant, maintain a pregnancy, or give birth to a live foetus. Fertilization is the process of increasing the number of sperms that reach the fallopian tubes in order to increase the chances of pregnancy. Intrauterine therapies are a type of fertility treatment that aims to increase the number of sperms entering a woman's uterus in order to increase her chances of becoming pregnant. In most developed economies, intrauterine insemination is a type of minimally invasive technique that is preferred over other fertilisation procedures.
Infertility testing market is expected to gain market growth at a potential rate of 3.2% in the forecast period of 2022 to 2029. Increasing cases of unintended pregnancies will enhance the growth of the market.
Definition
Infertility testing is a battery of tests used to figure out why a woman is unable to conceive. The tests also help determine whether the problem is with the man, the woman, or both. Infertility testing and evaluation are expensive, and the treatment can be uncomfortable at times. Male infertility tests include sperm penetration assays, DNA fragmentation, and oxidative stress analysis, whereas female infertility tests include laparoscopy, ovulation testing, hormone testing, and ovarian reserve testing. Infertility testing is done in research institutes, hospitals, fertility clinics, and clinics.
Report Scope and Market Segmentation
Report Metric
Details
Forecast Period
2022 to 2029
Base Year
2021
Historic Years
2020 (Customizable to 2014 - 2019)
Quantitative Units
Revenue in USD Million, Volumes in Units, Pricing in USD
Segments Covered
Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks),
Countries Covered
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
AB Scientific Ltd. (U.S.), Art Biotech Pvt. Ltd. (India), Cook (U.S.), Dxnow, Inc.(U.S), Eppendorf SE (U.S), Esco Micro Pte. Ltd. (Singapore), Hamilton Thorne, Ltd. (U.S), LabIVF Asia Pte Ltd. (Singapore), Rocket Medical plc (U.K), The Cooper Companies, Inc.(U.S), Vitrolife (Sweden), Irvine Scientific (U.S.), Microptic (U.S), The Cooper Companies Inc. (U.S.)
Drivers
Rising awareness among population about benefits of testing
Increasing cancer and thyroid occurrences; rising public awareness of the benefits of therapies; and increased investment in the development of advanced and technical solutions are some of the key factors that will drive the growth of the infertility testing market.
Increasing government support as well as rise in unplanned pregnancies
The rising rate of unintended pregnancies, supportive government initiatives, and an increasing number of private companies working to prevent unwanted abortions and pregnancies Furthermore, IUD devices are becoming more popular because they are effective, safe, and long-lasting, and they eliminate the need for other contraceptives.
Continuous research and development
In the forecast period, increased research activities will create advanced opportunities for the growth of the infertility testing market.
Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the Infertility testing market. Other factors such as increase in the demand for effective therapies and rising adoption rate for early genetic counselling will positively impact the Infertility testing market's growth rate. Additionally, high disposable income, rising number of cases of seizures and changing lifestyle will result in the expansion of Infertility testing market.
Restraints/Challenges
However, the high cost of treatment and testing, as well as the accuracy issues with testing kits, will impede market growth. The countries' regulatory issues will pose a challenge to the infertility testing market.
This infertility testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infertility testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Infertility testing Market
Countries all over the world had very little time to prepare for it. According to a UN survey, global lockdown will result in 7 million unwanted pregnancies due to the lack of modern contraceptives and other reproductive healthcare services, including intrauterine devices (IUDs). According to UNICEF, approximately 20 million babies would be born after the countries implemented lockdown. During the pandemic, women should avoid pregnancy not only for personal reasons, but also for public health reasons, though a shortage of Intrauterine therapies and other contraceptive methods has been a major issue.
Recent Developments
Modern Fertility will launch pregnancy and ovulation tests, as well as a mobile application to centralise all fertility-related data, in June 2020.
Proov received FDA approval for its at-home ovulation testing kit in March 2020.
Global Infertility testing Market Scope
The infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Female infertility testing
Male infertility testing
The infertility testing market is segmented on the basis of type into female infertility testing and male infertility testing. Female infertility testing has been further sub-segmented into ovulation testing, hysterosalpingography, laparoscopy, transvaginal ultrasound, ovarian reserve testing, hormone testing and others. Male infertility testing has been further sub-segmented into DNA fragmentation, oxidative stress analysis, sperm penetration assay, computer aided semen analysis, sperm agglutination assay, microscopic examination and others.
Test Kits
Follicular stimulating hormone (FSH) urine test kit
luteinizing hormone (LH) urine test kits
human chorionic gonadotropin (HCG) hormone blood test kits
others
On the basis of test kits, the infertility testing market is segmented into follicular stimulating hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits, and others.
Prescription Mode
Prescription based
Over the counter (OTC)
On the basis of prescription mode, the infertility testing market is segmented into prescription based and over the counter (OTC) based.
Distribution channel
Hospital pharmacies
Online pharmacies
Drug stores
On the basis of distribution channel, the infertility testing market is segmented into hospitals pharmacies, online pharmacies, pharmacies & drug stores.
End Use
Hospitals & clinics
Research institutes
Cryobanks
On the basis of end-user, the infertility testing market is segmented into fertility centers, hospitals and clinics, research institutes, and cryobanks.
The infertility testing market is analysed and market size insights and trends are provided by country, type, test kits, prescription mode, distribution channel and end-user as referenced above.
The countries covered in the infertility testing market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infertility testing market in terms of market share and revenue, and this dominance is expected to continue during the forecast period. This is due to the region's presence of major key players, well-developed healthcare infrastructure, and high disposable income. Asia-Pacific, on the other hand, is expected to grow at the fastest rate during the forecast period due to increased R&D activities, increased investment in the healthcare sector, and increased government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Infertility Testing MarketShare Analysis
The infertility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infertility testing market.
Some of the major players operating in the infertility testing market are
AB Scientific Ltd. (U.S.)
Art Biotech Pvt. Ltd. (India)
Cook (U.S.)
Dxnow, Inc.(U.S)
Eppendorf SE (U.S)
Esco Micro Pte. Ltd. (Singapore)
Hamilton Thorne, Ltd. (U.S)
LabIVF Asia Pte Ltd. (Singapore)
Rocket Medical plc (U.K)
The Cooper Companies, Inc.(U.S)
Vitrolife (Sweden)
Irvine Scientific (U.S.)
Microptic (U.S)
The Cooper Companies Inc. (U.S.)
SKU-15797
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Frequently Asked Questions
What are the primary segments covered in the Global Infertility Testing Market report?
The market is segmented based on , By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks), Industry Trends and Forecast to 2029
.
What is the current market size of the Global Infertility Testing Market?
The Global Infertility Testing Market size was valued at USD 0.00 USD Million in 2022.
What is the expected growth rate of the Global Infertility Testing Market?
The Global Infertility Testing Market is projected to grow at a CAGR of 3.2% during the forecast period of 2023 to 2029.
Who are the key players in the Global Infertility Testing Market?
The major players operating in the market include AB Scientific Ltd. , Art Biotech Pvt. Ltd. Cook , DxnowInc., Eppendorf SE , Esco Micro Pte. Ltd. , Hamilton ThorneLtd. , LabIVF Asia Pte Ltd. , Rocket Medical plc , The Cooper CompaniesInc., Vitrolife , Irvine Scientific , Microptic , The Cooper Companies Inc. .
Which countries are analyzed in the Global Infertility Testing Market report?
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future